Investor Presentation - First Six Months of 2021

17 Investor presentation First six months of 2021 Financial outlook for 2021 Sales growth - at CER Sales growth - reported Operating profit growth - at CER Expectations 4 August 2021 10% to 13% Expectations 5 May 2021 6% to 10% Around 4 percentage points lower Around 4 percentage points lower 9% to 12% 5% to 9% Operating profit growth - reported Around 5 percentage points lower Around 6 percentage points lower Financial items (net) Effective tax rate Free cash flow Gain of around DKK 0.6 billion Gain of around DKK 0.7 billion 19% to 21% DKK 39 to 44 billion 20% to 22% DKK 37 to 42 billion Note: Changes since last highlighted in bold The financial outlook is based on an assumption of a continuation of the current business environment and given the current scope of business activities and has been prepared assuming that currency exchange rates remain at the level as of 14 July 2021. Novo NordiskⓇ

View entire presentation